# Motorola Solutions, Inc.: financial statements, quarterly

MSI · NYSE · CIK 68505 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/msi.md) · [Financials](/companies/msi/financials.md) · [Filings](/companies/msi/filings.md) · [Insiders](/companies/msi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/msi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,556](/filings/0000068505-24-000034.md) | [2,849 d](/filings/0000068505-26-000010.md) | [2,389](/filings/0000068505-25-000024.md) | [2,628](/filings/0000068505-25-000040.md) | [2,790](/filings/0000068505-25-000052.md) | [3,011 d](/filings/0000068505-26-000010.md) | [2,528](/filings/0000068505-26-000021.md) | [2,765](/filings/0000068505-26-000028.md) | [3,009](/filings/0000068505-25-000052.md) | [3,380 d](/filings/0000068505-26-000010.md) | [2,714](/filings/0000068505-26-000021.md) | [3,133](/filings/0000068505-26-000028.md) |
| Cost of revenue | $m | [1,276](/filings/0000068505-24-000034.md) | [1,394 d](/filings/0000068505-26-000010.md) | [1,197](/filings/0000068505-25-000024.md) | [1,289](/filings/0000068505-25-000040.md) | [1,357](/filings/0000068505-25-000052.md) | [1,462 d](/filings/0000068505-26-000010.md) | [1,228](/filings/0000068505-26-000021.md) | [1,352](/filings/0000068505-26-000028.md) | [1,455](/filings/0000068505-25-000052.md) | [1,612 d](/filings/0000068505-26-000010.md) | [1,352](/filings/0000068505-26-000021.md) | [1,455](/filings/0000068505-26-000028.md) |
| Gross profit | $m | [1,280](/filings/0000068505-24-000034.md) | [1,455 d](/filings/0000068505-26-000010.md) | [1,192](/filings/0000068505-25-000024.md) | [1,339](/filings/0000068505-25-000040.md) | [1,433](/filings/0000068505-25-000052.md) | [1,549 d](/filings/0000068505-26-000010.md) | [1,300](/filings/0000068505-26-000021.md) | [1,413](/filings/0000068505-26-000028.md) | [1,554](/filings/0000068505-25-000052.md) | [1,768 d](/filings/0000068505-26-000010.md) | [1,362](/filings/0000068505-26-000021.md) | [1,678](/filings/0000068505-26-000028.md) |
| Research and development | $m | [215](/filings/0000068505-24-000034.md) | [218 d](/filings/0000068505-26-000010.md) | [218](/filings/0000068505-25-000024.md) | [220](/filings/0000068505-25-000040.md) | [234](/filings/0000068505-25-000052.md) | [246 d](/filings/0000068505-26-000010.md) | [233](/filings/0000068505-26-000021.md) | [231](/filings/0000068505-26-000028.md) | [237](/filings/0000068505-25-000052.md) | [270 d](/filings/0000068505-26-000010.md) | [252](/filings/0000068505-26-000021.md) | [260](/filings/0000068505-26-000028.md) |
| Selling, general and administrative | $m | [380](/filings/0000068505-24-000034.md) | [423 d](/filings/0000068505-26-000010.md) | [397](/filings/0000068505-25-000024.md) | [430](/filings/0000068505-25-000040.md) | [439](/filings/0000068505-25-000052.md) | [487 d](/filings/0000068505-26-000010.md) | [436](/filings/0000068505-26-000021.md) | [450](/filings/0000068505-26-000028.md) | [485](/filings/0000068505-25-000052.md) | [499 d](/filings/0000068505-26-000010.md) | [439](/filings/0000068505-26-000021.md) | [496](/filings/0000068505-26-000028.md) |
| Operating income | $m | [639](/filings/0000068505-24-000034.md) | [738 d](/filings/0000068505-26-000010.md) | [519](/filings/0000068505-25-000024.md) | [644](/filings/0000068505-25-000040.md) | [711](/filings/0000068505-25-000052.md) | [814 d](/filings/0000068505-26-000010.md) | [582](/filings/0000068505-26-000021.md) | [692](/filings/0000068505-26-000028.md) | [770](/filings/0000068505-25-000052.md) | [944 d](/filings/0000068505-26-000010.md) | [525](/filings/0000068505-26-000021.md) | [809](/filings/0000068505-26-000028.md) |
| Interest expense | $m | [60.0](/filings/0000068505-24-000034.md) | [63.0 d](/filings/0000068505-26-000010.md) | [61.0](/filings/0000068505-25-000024.md) | [87.0](/filings/0000068505-25-000040.md) | [73.0](/filings/0000068505-25-000052.md) | [74.0 d](/filings/0000068505-26-000010.md) | [69.0](/filings/0000068505-26-000021.md) | [71.0](/filings/0000068505-26-000028.md) | [103](/filings/0000068505-25-000052.md) | [117 d](/filings/0000068505-26-000010.md) | [111](/filings/0000068505-26-000021.md) | [109](/filings/0000068505-26-000028.md) |
| Income tax | $m | [127](/filings/0000068505-24-000034.md) | [111 d](/filings/0000068505-26-000010.md) | [(52.0)](/filings/0000068505-25-000024.md) | [135](/filings/0000068505-25-000040.md) | [132](/filings/0000068505-25-000052.md) | [176 d](/filings/0000068505-26-000010.md) | [115](/filings/0000068505-26-000021.md) | [165](/filings/0000068505-26-000028.md) | [161](/filings/0000068505-25-000052.md) | [210 d](/filings/0000068505-26-000010.md) | [73.0](/filings/0000068505-26-000021.md) | [184](/filings/0000068505-26-000028.md) |
| Net income | $m | [464](/filings/0000068505-24-000034.md) | [596 d](/filings/0000068505-26-000010.md) | [(39.0)](/filings/0000068505-25-000024.md) | [443](/filings/0000068505-25-000040.md) | [562](/filings/0000068505-25-000052.md) | [611 d](/filings/0000068505-26-000010.md) | [430](/filings/0000068505-26-000021.md) | [513](/filings/0000068505-26-000028.md) | [562](/filings/0000068505-25-000052.md) | [649 d](/filings/0000068505-26-000010.md) | [366](/filings/0000068505-26-000021.md) | [557](/filings/0000068505-26-000028.md) |
| Diluted EPS | $ per share | [2.70](/filings/0000068505-24-000034.md) | not reported | [(0.23)](/filings/0000068505-25-000024.md) | [2.60](/filings/0000068505-25-000040.md) | [3.29](/filings/0000068505-25-000052.md) | not reported | [2.53](/filings/0000068505-26-000021.md) | [3.04](/filings/0000068505-26-000028.md) | [3.33](/filings/0000068505-25-000052.md) | not reported | [2.18](/filings/0000068505-26-000021.md) | [3.33](/filings/0000068505-26-000028.md) |
| Basic EPS | $ per share | [2.78](/filings/0000068505-24-000034.md) | not reported | [(0.23)](/filings/0000068505-25-000024.md) | [2.65](/filings/0000068505-25-000040.md) | [3.36](/filings/0000068505-25-000052.md) | not reported | [2.58](/filings/0000068505-26-000021.md) | [3.08](/filings/0000068505-26-000028.md) | [3.37](/filings/0000068505-25-000052.md) | not reported | [2.21](/filings/0000068505-26-000021.md) | [3.36](/filings/0000068505-26-000028.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.9](/filings/0000068505-23-000045.md) | [1.7](/filings/0000068505-25-000012.md) | [1.5](/filings/0000068505-24-000016.md) | [1.4](/filings/0000068505-24-000024.md) | [1.4](/filings/0000068505-24-000034.md) | [2.1](/filings/0000068505-26-000010.md) | [1.6](/filings/0000068505-25-000024.md) | [3.2](/filings/0000068505-25-000040.md) | [0.9](/filings/0000068505-25-000052.md) | [1.2](/filings/0000068505-26-000028.md) | [0.9](/filings/0000068505-26-000021.md) | [0.7](/filings/0000068505-26-000028.md) |
| Current assets | $bn | [5.0](/filings/0000068505-23-000045.md) | [5.7](/filings/0000068505-25-000012.md) | [5.5](/filings/0000068505-24-000016.md) | [5.6](/filings/0000068505-24-000024.md) | [5.8](/filings/0000068505-24-000034.md) | [6.5](/filings/0000068505-26-000010.md) | [5.9](/filings/0000068505-25-000024.md) | [7.7](/filings/0000068505-25-000040.md) | [5.8](/filings/0000068505-25-000052.md) | [6.3](/filings/0000068505-26-000028.md) | [6.0](/filings/0000068505-26-000021.md) | [6.1](/filings/0000068505-26-000028.md) |
| Total assets | $bn | [12.4](/filings/0000068505-23-000045.md) | [13.3](/filings/0000068505-26-000010.md) | [13.3](/filings/0000068505-24-000016.md) | [13.3](/filings/0000068505-24-000024.md) | [13.9](/filings/0000068505-24-000034.md) | [14.6](/filings/0000068505-26-000010.md) | [14.4](/filings/0000068505-25-000024.md) | [16.4](/filings/0000068505-25-000040.md) | [18.8](/filings/0000068505-25-000052.md) | [19.4](/filings/0000068505-26-000028.md) | [19.1](/filings/0000068505-26-000021.md) | [19.2](/filings/0000068505-26-000028.md) |
| Current liabilities | $bn | [5.3](/filings/0000068505-23-000045.md) | [5.7](/filings/0000068505-25-000012.md) | [4.6](/filings/0000068505-24-000016.md) | [4.6](/filings/0000068505-24-000024.md) | [4.7](/filings/0000068505-24-000034.md) | [5.1](/filings/0000068505-26-000010.md) | [4.9](/filings/0000068505-25-000024.md) | [4.5](/filings/0000068505-25-000040.md) | [5.7](/filings/0000068505-25-000052.md) | [6.1](/filings/0000068505-26-000028.md) | [5.6](/filings/0000068505-26-000021.md) | [5.6](/filings/0000068505-26-000028.md) |
| Long-term debt | $bn | [4.7](/filings/0000068505-23-000045.md) | [4.7](/filings/0000068505-25-000012.md) | [6.0](/filings/0000068505-24-000016.md) | [5.7](/filings/0000068505-24-000024.md) | [5.7](/filings/0000068505-24-000034.md) | [5.7](/filings/0000068505-26-000010.md) | [5.7](/filings/0000068505-25-000024.md) | [7.7](/filings/0000068505-25-000040.md) | [8.4](/filings/0000068505-25-000052.md) | [8.4](/filings/0000068505-26-000028.md) | [8.4](/filings/0000068505-26-000021.md) | [8.4](/filings/0000068505-26-000028.md) |
| Current portion of debt | $bn | [1.3](/filings/0000068505-23-000045.md) | [1.3](/filings/0000068505-25-000012.md) | [0.3](/filings/0000068505-24-000016.md) | [0.6](/filings/0000068505-24-000024.md) | [0.3](/filings/0000068505-24-000034.md) | [0.3](/filings/0000068505-26-000010.md) | [0.3](/filings/0000068505-25-000024.md) | [0.1](/filings/0000068505-25-000040.md) | [0.0](/filings/0000068505-25-000052.md) | [0.0](/filings/0000068505-26-000010.md) | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0000068505-26-000010.md) | not reported | not reported | [0.9](/filings/0000068505-25-000052.md) | [0.7](/filings/0000068505-26-000028.md) | [0.6](/filings/0000068505-26-000021.md) | [0.6](/filings/0000068505-26-000028.md) |
| Shareholders' equity | $bn | [0.4](/filings/0000068505-23-000045.md) | [0.7](/filings/0000068505-25-000012.md) | [0.5](/filings/0000068505-24-000016.md) | [0.8](/filings/0000068505-24-000024.md) | [1.3](/filings/0000068505-24-000034.md) | [1.7](/filings/0000068505-26-000010.md) | [1.6](/filings/0000068505-25-000024.md) | [2.0](/filings/0000068505-25-000040.md) | [2.3](/filings/0000068505-25-000052.md) | [2.4](/filings/0000068505-26-000028.md) | [2.5](/filings/0000068505-26-000021.md) | [2.7](/filings/0000068505-26-000028.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent, us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [714 d](/filings/0000068505-24-000034.md) | [1,245 d](/filings/0000068505-26-000010.md) | [382](/filings/0000068505-25-000024.md) | [180 d](/filings/0000068505-25-000040.md) | [759 d](/filings/0000068505-25-000052.md) | [1,070 d](/filings/0000068505-26-000010.md) | [510](/filings/0000068505-26-000021.md) | [273 d](/filings/0000068505-26-000028.md) | [798 d](/filings/0000068505-25-000052.md) | [1,256 d](/filings/0000068505-26-000010.md) | [451](/filings/0000068505-26-000021.md) | [469 d](/filings/0000068505-26-000028.md) |
| Capital expenditure | $m | [65.0 d](/filings/0000068505-24-000034.md) | [81.0 d](/filings/0000068505-26-000010.md) | [46.0](/filings/0000068505-25-000024.md) | [68.0](/filings/0000068505-25-000040.md) | [57.0](/filings/0000068505-25-000052.md) | [86.0 d](/filings/0000068505-26-000010.md) | [37.0](/filings/0000068505-26-000021.md) | [48.0](/filings/0000068505-25-000040.md) | [66.0](/filings/0000068505-25-000052.md) | [114 d](/filings/0000068505-26-000010.md) | [62.0](/filings/0000068505-26-000021.md) | [55.0 d](/filings/0000068505-26-000028.md) |
| Dividends paid | $m | [147](/filings/0000068505-24-000034.md) | [146 d](/filings/0000068505-26-000010.md) | [163](/filings/0000068505-25-000024.md) | [163](/filings/0000068505-25-000040.md) | [164](/filings/0000068505-25-000052.md) | [164 d](/filings/0000068505-26-000010.md) | [182](/filings/0000068505-26-000021.md) | [182](/filings/0000068505-26-000028.md) | [182](/filings/0000068505-25-000052.md) | [182 d](/filings/0000068505-26-000010.md) | [201](/filings/0000068505-26-000021.md) | [201](/filings/0000068505-26-000028.md) |
| Share repurchases | $m | [306](/filings/0000068505-23-000045.md) | [134 d](/filings/0000068505-26-000010.md) | [39.0](/filings/0000068505-25-000024.md) | [71.0 d](/filings/0000068505-25-000040.md) | [31.0 d](/filings/0000068505-25-000052.md) | [103 d](/filings/0000068505-26-000010.md) | [325](/filings/0000068505-26-000021.md) | [218 d](/filings/0000068505-26-000028.md) | [121 d](/filings/0000068505-25-000052.md) | [490 d](/filings/0000068505-26-000010.md) | [118](/filings/0000068505-26-000021.md) | [331 d](/filings/0000068505-26-000028.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [172](/filings/0000068505-23-000045.md) | [173](/filings/0000068505-24-000016.md) | [173](/filings/0000068505-24-000024.md) | [172](/filings/0000068505-24-000034.md) | [166](/filings/0000068505-25-000024.md) | [170](/filings/0000068505-25-000040.md) | [171](/filings/0000068505-25-000052.md) | [170](/filings/0000068505-26-000021.md) | [169](/filings/0000068505-26-000028.md) | [169](/filings/0000068505-25-000052.md) | [168](/filings/0000068505-26-000021.md) | [167](/filings/0000068505-26-000028.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 165,493,788 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0000068505-26-000028.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.